-
1
-
-
0033870513
-
A combined PET/CT scanner for clinical oncology
-
Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41:1369-1379.
-
(2000)
J Nucl Med
, vol.41
, pp. 1369-1379
-
-
Beyer, T.1
Townsend, D.W.2
Brun, T.3
-
2
-
-
45249101890
-
-
von Schulthess GK. Clinical Molecular Anatomic Imaging, PET, PET/CT and SPECT/CT. Lippincott, Williams and Wilkins, 2003.
-
von Schulthess GK. Clinical Molecular Anatomic Imaging, PET, PET/CT and SPECT/CT. Lippincott, Williams and Wilkins, 2003.
-
-
-
-
3
-
-
0036829409
-
PET diagnostic accuracy: Improvement with in-line PET-CT system: initial results
-
Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 2002; 225:575-581.
-
(2002)
Radiology
, vol.225
, pp. 575-581
-
-
Hany, T.F.1
Steinert, H.C.2
Goerres, G.W.3
Buck, A.4
von Schulthess, G.K.5
-
4
-
-
0031791001
-
Attenuation correction for a combined 3D PET/CT scanner
-
Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med Phys 1998; 25:2046-2053.
-
(1998)
Med Phys
, vol.25
, pp. 2046-2053
-
-
Kinahan, P.E.1
Townsend, D.W.2
Beyer, T.3
Sashin, D.4
-
5
-
-
0036093165
-
PET attenuation coefficients from CT images: Experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients
-
Burger C, Goerres G, Schoenes S, Buck A, Lonn AH, Von Schulthess GK. PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients. Eur J Nucl Med Mol Imaging 2002;29:922-927.
-
(2002)
Eur J Nucl Med Mol Imaging
, vol.29
, pp. 922-927
-
-
Burger, C.1
Goerres, G.2
Schoenes, S.3
Buck, A.4
Lonn, A.H.5
Von Schulthess, G.K.6
-
6
-
-
33646465432
-
Performance evaluation of the PET sub-systems of two PET/CT imagers according to NEMA standard NU 2-2001
-
Strigl M, Martinez MJ, Zach C, Ziegler SI, Hahn K. Performance evaluation of the PET sub-systems of two PET/CT imagers according to NEMA standard NU 2-2001. Z Med Phys 2006; 16:83-91.
-
(2006)
Z Med Phys
, vol.16
, pp. 83-91
-
-
Strigl, M.1
Martinez, M.J.2
Zach, C.3
Ziegler, S.I.4
Hahn, K.5
-
7
-
-
33745893221
-
-
Martinez MJ, Bercier Y, Schwaiger M, Ziegler SI. PET/CT Biograph Sensation 16. Performance improvement using faster electronics. Nuklearmedizin 2006; 45:126-133.
-
Martinez MJ, Bercier Y, Schwaiger M, Ziegler SI. PET/CT Biograph Sensation 16. Performance improvement using faster electronics. Nuklearmedizin 2006; 45:126-133.
-
-
-
-
8
-
-
34247204476
-
NEMA NU 2-2001 performance measurements of an LYSO-based PET/CT system in 2D and 3D acquisition modes
-
Kemp BJ, Kim C, Williams JJ, Ganin A, Lowe VJ. NEMA NU 2-2001 performance measurements of an LYSO-based PET/CT system in 2D and 3D acquisition modes. J Nucl Med 2006; 47:1960-1967.
-
(2006)
J Nucl Med
, vol.47
, pp. 1960-1967
-
-
Kemp, B.J.1
Kim, C.2
Williams, J.J.3
Ganin, A.4
Lowe, V.J.5
-
9
-
-
34247230296
-
Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities
-
Surti S, Kuhn A, Werner ME, Perkins AE, Kolthammer J, Karp JS. Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med 2007; 48:471-480.
-
(2007)
J Nucl Med
, vol.48
, pp. 471-480
-
-
Surti, S.1
Kuhn, A.2
Werner, M.E.3
Perkins, A.E.4
Kolthammer, J.5
Karp, J.S.6
-
10
-
-
34249815204
-
Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system
-
Strobel K, Rudy M, Treyer V, Veit-Haibach P, Burger C, Hany TF. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system. Nucl Med Commun 2007; 28:555-559.
-
(2007)
Nucl Med Commun
, vol.28
, pp. 555-559
-
-
Strobel, K.1
Rudy, M.2
Treyer, V.3
Veit-Haibach, P.4
Burger, C.5
Hany, T.F.6
-
11
-
-
0037783428
-
CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET
-
Visvikis D, Costa DC, Croasdale I, et al. CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET. Eur J Nucl Med Mol Imaging 2003; 30:344-353.
-
(2003)
Eur J Nucl Med Mol Imaging
, vol.30
, pp. 344-353
-
-
Visvikis, D.1
Costa, D.C.2
Croasdale, I.3
-
12
-
-
1542681656
-
Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT
-
Nehmeh SA, Erdi YE, Kalaigian H, et al. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT. J Nucl Med 2003; 44:1940-1944.
-
(2003)
J Nucl Med
, vol.44
, pp. 1940-1944
-
-
Nehmeh, S.A.1
Erdi, Y.E.2
Kalaigian, H.3
-
13
-
-
0037369944
-
Respiration-induced attenuation artifact at PET/CT: Technical considerations
-
Goerres GW, Burger C, Kamel E, et al. Respiration-induced attenuation artifact at PET/CT: technical considerations. Radiology 2003; 226:906-910.
-
(2003)
Radiology
, vol.226
, pp. 906-910
-
-
Goerres, G.W.1
Burger, C.2
Kamel, E.3
-
14
-
-
0036209759
-
CT vs 68Ge attenuation correction in a combined PET/CT system: Evaluation of the effect of lowering the CT tube current
-
Kamel E, Hany TF, Burger C, et al. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Eur J Nucl Med Mol Imaging 2002; 29:346-350.
-
(2002)
Eur J Nucl Med Mol Imaging
, vol.29
, pp. 346-350
-
-
Kamel, E.1
Hany, T.F.2
Burger, C.3
-
15
-
-
13844294023
-
The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: Long-term outcome of treatment with imatinib mesylate
-
Goerres GW, Stupp R, Barghouth G, et al. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging 2005; 32:153-162.
-
(2005)
Eur J Nucl Med Mol Imaging
, vol.32
, pp. 153-162
-
-
Goerres, G.W.1
Stupp, R.2
Barghouth, G.3
-
16
-
-
0347635289
-
Positron emission tomography in the early follow-up of advanced head and neck cancer
-
discussion 120-121
-
Goerres GW, Schmid DT, Bandhauer F, et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2004; 130:105-109; discussion 120-121.
-
(2004)
Arch Otolaryngol Head Neck Surg
, vol.130
, pp. 105-109
-
-
Goerres, G.W.1
Schmid, D.T.2
Bandhauer, F.3
-
17
-
-
0037792992
-
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography
-
Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348:2500-2507.
-
(2003)
N Engl J Med
, vol.348
, pp. 2500-2507
-
-
Lardinois, D.1
Weder, W.2
Hany, T.F.3
-
18
-
-
13244296615
-
PET/CT using 18F-FDG in suspected lung cancer recurrence: Diagnostic value and impact on patient management
-
Keidar Z, Haim N, Guralnik L, et al. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med 2004; 45:1640-1646.
-
(2004)
J Nucl Med
, vol.45
, pp. 1640-1646
-
-
Keidar, Z.1
Haim, N.2
Guralnik, L.3
-
19
-
-
0142240448
-
Non-small cell lung cancer: Dual-modality PET/CT in preoperative staging
-
Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003; 229:526-533.
-
(2003)
Radiology
, vol.229
, pp. 526-533
-
-
Antoch, G.1
Stattaus, J.2
Nemat, A.T.3
-
20
-
-
0141615676
-
Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study
-
Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 2003; 57:853-863.
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.57
, pp. 853-863
-
-
Ciernik, I.F.1
Dizendorf, E.2
Baumert, B.G.3
-
22
-
-
35348895582
-
Whole-body PET/CT-colonography: A possible new concept for colorectal cancer staging
-
Kinner S, Antoch G, Bockisch A, Veit-Haibach P. Whole-body PET/CT-colonography: a possible new concept for colorectal cancer staging. Abdom Imaging 2007.
-
(2007)
Abdom Imaging
-
-
Kinner, S.1
Antoch, G.2
Bockisch, A.3
Veit-Haibach, P.4
-
23
-
-
29244488779
-
Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: Technical feasibility and first experiences in patients with colorectal cancer
-
Veit P, Kuhle C, Beyer T, et al. Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: technical feasibility and first experiences in patients with colorectal cancer. Gut 2006; 55:68-73.
-
(2006)
Gut
, vol.55
, pp. 68-73
-
-
Veit, P.1
Kuhle, C.2
Beyer, T.3
-
24
-
-
33845400192
-
Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography
-
Veit-Haibach P, Kuehle CA, Beyer T, et al. Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography. Jama 2006; 296:2590-2600.
-
(2006)
Jama
, vol.296
, pp. 2590-2600
-
-
Veit-Haibach, P.1
Kuehle, C.A.2
Beyer, T.3
-
25
-
-
0032125444
-
Surgery for recurrent colon cancer: Strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group
-
Goldberg RM, Fleming TR, Tangen CM, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998; 129:27-35.
-
(1998)
Ann Intern Med
, vol.129
, pp. 27-35
-
-
Goldberg, R.M.1
Fleming, T.R.2
Tangen, C.M.3
-
26
-
-
0642284535
-
Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma
-
Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003; 44:1797-1803.
-
(2003)
J Nucl Med
, vol.44
, pp. 1797-1803
-
-
Cohade, C.1
Osman, M.2
Leal, J.3
Wahl, R.L.4
-
27
-
-
10044237741
-
Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
-
discussion 1035-1036
-
Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004; 240:1027-1034; discussion 1035-1036.
-
(2004)
Ann Surg
, vol.240
, pp. 1027-1034
-
-
Selzner, M.1
Hany, T.F.2
Wildbrett, P.3
McCormack, L.4
Kadry, Z.5
Clavien, P.A.6
-
28
-
-
2342561799
-
-
Antoch G, Kanja J, Bauer S, et al. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. J Nucl Med 2004; 45:357-365.
-
Antoch G, Kanja J, Bauer S, et al. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. J Nucl Med 2004; 45:357-365.
-
-
-
-
29
-
-
0031593417
-
Whole-body 2-[18F]-fluoro-2- deoxy-D-glucose positron emission tomography (FDGPET) for accurate staging of Hodgkin's disease
-
Bangerter M, Moog F, Buchmann I, et al. Whole-body 2-[18F]-fluoro-2- deoxy-D-glucose positron emission tomography (FDGPET) for accurate staging of Hodgkin's disease. Ann Oncol 1998; 9:1117-1122.
-
(1998)
Ann Oncol
, vol.9
, pp. 1117-1122
-
-
Bangerter, M.1
Moog, F.2
Buchmann, I.3
-
30
-
-
0030988191
-
Lymphoma: Role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging
-
Moog F, Bangerter M, Diederichs CG, et al. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology 1997; 203:795-800.
-
(1997)
Radiology
, vol.203
, pp. 795-800
-
-
Moog, F.1
Bangerter, M.2
Diederichs, C.G.3
-
31
-
-
0031869324
-
Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: Effectiveness and comparison with computed tomography
-
Stumpe KD, Urbinelli M, Steinert HC, Glanzmann C, Buck A, von Schulthess GK. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. Eur J Nucl Med 1998; 25:721-728.
-
(1998)
Eur J Nucl Med
, vol.25
, pp. 721-728
-
-
Stumpe, K.D.1
Urbinelli, M.2
Steinert, H.C.3
Glanzmann, C.4
Buck, A.5
von Schulthess, G.K.6
-
32
-
-
0036434696
-
The value of positron emission tomography (PET) imaging in disease staging and therapy assessment
-
Jerusalem G, Hustinx R, Beguin Y, Fillet G. The value of positron emission tomography (PET) imaging in disease staging and therapy assessment. Ann Oncol 2002; 13:227-234.
-
(2002)
Ann Oncol
, vol.13
, pp. 227-234
-
-
Jerusalem, G.1
Hustinx, R.2
Beguin, Y.3
Fillet, G.4
-
33
-
-
0036344772
-
Positron emission tomography in non-Hodgkin's lymphoma (NHL): Relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL
-
Jerusalem GH, Beguin YP. Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL. Clin Lymphoma 2002; 3:56-61.
-
(2002)
Clin Lymphoma
, vol.3
, pp. 56-61
-
-
Jerusalem, G.H.1
Beguin, Y.P.2
-
34
-
-
0242266441
-
18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma
-
Zijlstra JM, Hoekstra OS, Raijmakers PG, et al. 18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma. Br J Haematol 2003; 123:454-462.
-
(2003)
Br J Haematol
, vol.123
, pp. 454-462
-
-
Zijlstra, J.M.1
Hoekstra, O.S.2
Raijmakers, P.G.3
-
35
-
-
0037083501
-
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma
-
Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer 2002; 94:879-888.
-
(2002)
Cancer
, vol.94
, pp. 879-888
-
-
Kostakoglu, L.1
Leonard, J.P.2
Kuji, I.3
Coleman, M.4
Vallabhajosula, S.5
Goldsmith, S.J.6
-
36
-
-
2442636731
-
PETCT of extranodal lymphoma
-
Metser U, Goor O, Lerman H, Naparstek E, Even-Sapir E. PETCT of extranodal lymphoma. AJR Am J Roentgenol 2004; 182:1579-1586.
-
(2004)
AJR Am J Roentgenol
, vol.182
, pp. 1579-1586
-
-
Metser, U.1
Goor, O.2
Lerman, H.3
Naparstek, E.4
Even-Sapir, E.5
-
37
-
-
4143066762
-
Non-Hodgkin lymphoma and Hodgkin disease: Coregistered FDG PET and CT at staging and restaging - do we need contrast-enhanced CT?
-
Schaefer NG, Hany TF, Taverna C, et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging - do we need contrast-enhanced CT? Radiology 2004; 232:823-829.
-
(2004)
Radiology
, vol.232
, pp. 823-829
-
-
Schaefer, N.G.1
Hany, T.F.2
Taverna, C.3
-
39
-
-
34047107851
-
Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18]fluoro-2-deoxy-D-glucose- positron emission tomography/computed tomography: Is an end of treatment exam necessary in all patients?
-
Strobel K, Schaefer NG, Renner C, et al. Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18]fluoro-2-deoxy-D-glucose- positron emission tomography/computed tomography: is an end of treatment exam necessary in all patients? Ann Oncol 2007; 18:658-664.
-
(2007)
Ann Oncol
, vol.18
, pp. 658-664
-
-
Strobel, K.1
Schaefer, N.G.2
Renner, C.3
-
40
-
-
1642275593
-
Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion
-
Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004; 231:65-72.
-
(2004)
Radiology
, vol.231
, pp. 65-72
-
-
Schoder, H.1
Yeung, H.W.2
Gonen, M.3
Kraus, D.4
Larson, S.M.5
-
41
-
-
16544390982
-
Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: Correlation with endoscopic and histopathologic results
-
Kamel EM, Thumshirn M, Truninger K, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med 2004; 45:1804-1810.
-
(2004)
J Nucl Med
, vol.45
, pp. 1804-1810
-
-
Kamel, E.M.1
Thumshirn, M.2
Truninger, K.3
-
42
-
-
5444275916
-
Investigation of thyroid, head, and neck cancers with PET
-
Zhuang H, Kumar R, Mandel S, Alavi A. Investigation of thyroid, head, and neck cancers with PET. Radiol Clin North Am 2004; 42:1101-1111.
-
(2004)
Radiol Clin North Am
, vol.42
, pp. 1101-1111
-
-
Zhuang, H.1
Kumar, R.2
Mandel, S.3
Alavi, A.4
-
43
-
-
1242338156
-
Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?
-
Rogers JW, Greven KM, McGuirt WF, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 2004; 58:694-697.
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.58
, pp. 694-697
-
-
Rogers, J.W.1
Greven, K.M.2
McGuirt, W.F.3
-
44
-
-
1842764968
-
FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: Comparison with MRI/CT
-
Kubota K, Yokoyama J, Yamaguchi K, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004; 31:590-595.
-
(2004)
Eur J Nucl Med Mol Imaging
, vol.31
, pp. 590-595
-
-
Kubota, K.1
Yokoyama, J.2
Yamaguchi, K.3
-
45
-
-
34047214644
-
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer
-
Shammas A, Degirmenci B, Mountz JM, et al. 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer. J Nucl Med 2007; 48:221-226.
-
(2007)
J Nucl Med
, vol.48
, pp. 221-226
-
-
Shammas, A.1
Degirmenci, B.2
Mountz, J.M.3
-
46
-
-
33744920603
-
Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma
-
Petrowsky H, Wildbrett P, Husarik DB, et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 2006; 45:43-50.
-
(2006)
J Hepatol
, vol.45
, pp. 43-50
-
-
Petrowsky, H.1
Wildbrett, P.2
Husarik, D.B.3
-
47
-
-
22744437710
-
Positron emission tomography/Computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness
-
Heinrich S, Goerres GW, Schäfer M, et al. Positron emission tomography/Computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg 2005; 242: 235-243.
-
(2005)
Ann Surg
, vol.242
, pp. 235-243
-
-
Heinrich, S.1
Goerres, G.W.2
Schäfer, M.3
-
48
-
-
7044232022
-
Integrated FDG PET/CT in patients with persistent ovarian cancer: Correlation with histologic findings
-
Sironi S, Messa C, Mangili G, et al. Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings. Radiology 2004; 233:433-440.
-
(2004)
Radiology
, vol.233
, pp. 433-440
-
-
Sironi, S.1
Messa, C.2
Mangili, G.3
-
49
-
-
2342620155
-
PETCT detection of abdominal recurrence of ovarian cancer: Radiologic-surgical correlation
-
Pannu HK, Cohade C, Bristow RE, Fishman EK, Wahl RL. PETCT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation. Abdom Imaging 2004; 29: 398-403.
-
(2004)
Abdom Imaging
, vol.29
, pp. 398-403
-
-
Pannu, H.K.1
Cohade, C.2
Bristow, R.E.3
Fishman, E.K.4
Wahl, R.L.5
-
50
-
-
12444321927
-
Advanced ovarian carcinoma: Usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment
-
Picchio M, Sironi S, Messa C, et al. Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment. Q J Nucl Med 2003; 47:77-84.
-
(2003)
Q J Nucl Med
, vol.47
, pp. 77-84
-
-
Picchio, M.1
Sironi, S.2
Messa, C.3
-
51
-
-
0026550050
-
Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone
-
Perez CA, Grigsby PW, Nene SM, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992; 69:2796-2806.
-
(1992)
Cancer
, vol.69
, pp. 2796-2806
-
-
Perez, C.A.1
Grigsby, P.W.2
Nene, S.M.3
-
52
-
-
0025047543
-
Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: Extended diagnostic evaluation for paraaortic node metastasis - a Gynecologic Oncology Group study
-
Heller PB, Maletano JH, Bundy BN, Barnhill DR, Okagaki T. Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis - a Gynecologic Oncology Group study. Gynecol Oncol 1990; 38:425-430.
-
(1990)
Gynecol Oncol
, vol.38
, pp. 425-430
-
-
Heller, P.B.1
Maletano, J.H.2
Bundy, B.N.3
Barnhill, D.R.4
Okagaki, T.5
-
53
-
-
0035449659
-
Lymph node staging by positron emission tomography in patients with carcinoma of the cervix
-
Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001; 19:3745-3749.
-
(2001)
J Clin Oncol
, vol.19
, pp. 3745-3749
-
-
Grigsby, P.W.1
Siegel, B.A.2
Dehdashti, F.3
-
54
-
-
29444450845
-
Lymph node metastasis in patients with clinical early-stage cervical cancer: Detection with integrated FDG PET/CT
-
Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 2006; 238:272-279.
-
(2006)
Radiology
, vol.238
, pp. 272-279
-
-
Sironi, S.1
Buda, A.2
Picchio, M.3
-
55
-
-
4444330328
-
The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies
-
Grisaru D, Almog B, Levine C, et al. The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies. Gynecol Oncol 2004; 94:680-684.
-
(2004)
Gynecol Oncol
, vol.94
, pp. 680-684
-
-
Grisaru, D.1
Almog, B.2
Levine, C.3
-
56
-
-
1542399591
-
Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: Assessment by PET/CT
-
Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J Nucl Med 2004; 45:266-271.
-
(2004)
J Nucl Med
, vol.45
, pp. 266-271
-
-
Lerman, H.1
Metser, U.2
Grisaru, D.3
Fishman, A.4
Lievshitz, G.5
Even-Sapir, E.6
-
57
-
-
34548316990
-
FDG-PET/CT in restaging of patients with recurrent breast cancer: Possible impact on staging and therapy
-
Veit-Haibach P, Antoch G, Beyer T, et al. FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy. Br J Radiol 2007.
-
(2007)
Br J Radiol
-
-
Veit-Haibach, P.1
Antoch, G.2
Beyer, T.3
-
58
-
-
33644893903
-
Performance of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients
-
Fueger BJ, Weber WA, Quon A, et al. Performance of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients. Mol Imaging Biol 2005; 7:369-376.
-
(2005)
Mol Imaging Biol
, vol.7
, pp. 369-376
-
-
Fueger, B.J.1
Weber, W.A.2
Quon, A.3
-
59
-
-
3042579577
-
PET/CT and breast cancer
-
Zangheri B, Messa C, Picchio M, Gianolli L, Landoni C, Fazio F. PET/CT and breast cancer. Eur J Nucl Med Mol Imaging 2004; 31 Suppl 1:S135-142.
-
(2004)
Eur J Nucl Med Mol Imaging
, vol.31
, Issue.SUPPL. 1
-
-
Zangheri, B.1
Messa, C.2
Picchio, M.3
Gianolli, L.4
Landoni, C.5
Fazio, F.6
-
60
-
-
34548184430
-
Tumour assessment in advanced melanoma: Value of FDG-PET/CT in patients with elevated serum S-100B
-
Strobel K, Skalsky J, Kalff V, et al. Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B. Eur J Nucl Med Mol Imaging 2007.
-
(2007)
Eur J Nucl Med Mol Imaging
-
-
Strobel, K.1
Skalsky, J.2
Kalff, V.3
-
61
-
-
0037256929
-
Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy
-
Rohren EM, Provenzale JM, Barboriak DP, Coleman RE. Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy. Radiology 2003; 226:181-187.
-
(2003)
Radiology
, vol.226
, pp. 181-187
-
-
Rohren, E.M.1
Provenzale, J.M.2
Barboriak, D.P.3
Coleman, R.E.4
-
62
-
-
17644416782
-
Fluorocholine PET/CT in patients with prostate cancer: Initial experience
-
Schmid DT, John H, Zweifel R, et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology 2005; 235:623-628.
-
(2005)
Radiology
, vol.235
, pp. 623-628
-
-
Schmid, D.T.1
John, H.2
Zweifel, R.3
-
63
-
-
1642553328
-
Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation
-
Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004; 31:29-37.
-
(2004)
Eur J Nucl Med Mol Imaging
, vol.31
, pp. 29-37
-
-
Bleeker-Rovers, C.P.1
de Kleijn, E.M.2
Corstens, F.H.3
van der Meer, J.W.4
Oyen, W.J.5
-
64
-
-
17144473334
-
Fluorine-18 fluorodeoxyglucose-position emission tomography: A highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections
-
de Winter F, van de Wiele C, Vogelaers D, de Smet K, Verdonk R, Dierckx RA. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 2001; 83-A:651-660.
-
(2001)
J Bone Joint Surg Am
, vol.83-A
, pp. 651-660
-
-
de Winter, F.1
van de Wiele, C.2
Vogelaers, D.3
de Smet, K.4
Verdonk, R.5
Dierckx, R.A.6
-
65
-
-
0037908634
-
-
Keidar Z, Engel A, Nitecki S, Bar Shalom R, Hoffman A, Israel O. PET/CT using 2-deoxy-2-[18F]fluoro-D-glucose for the evaluation of suspected infected vascular graft. Mol Imaging Biol 2003; 5:23-25.
-
Keidar Z, Engel A, Nitecki S, Bar Shalom R, Hoffman A, Israel O. PET/CT using 2-deoxy-2-[18F]fluoro-D-glucose for the evaluation of suspected infected vascular graft. Mol Imaging Biol 2003; 5:23-25.
-
-
-
-
66
-
-
0037293292
-
Detection of metallic implant-associated infections with FDG PET in patients with trauma: Correlation with microbiologic results
-
Schiesser M, Stumpe KD, Trentz O, Kossmann T, Von Schulthess GK. Detection of metallic implant-associated infections with FDG PET in patients with trauma: correlation with microbiologic results. Radiology 2003; 226:391-398.
-
(2003)
Radiology
, vol.226
, pp. 391-398
-
-
Schiesser, M.1
Stumpe, K.D.2
Trentz, O.3
Kossmann, T.4
Von Schulthess, G.K.5
-
67
-
-
2142762421
-
FDG PET for differentiation of infection and aseptic loosening in total hip replacements: Comparison with conventional radiography and three-phase bone scintigraphy
-
Stumpe KD, Nötzli HP, Zanetti M, et al. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. Radiology 2004; 231:333-341.
-
(2004)
Radiology
, vol.231
, pp. 333-341
-
-
Stumpe, K.D.1
Nötzli, H.P.2
Zanetti, M.3
|